MedTrace Logo

Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain

NCT02022722 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2013-12-30

No results posted yet for this study

Summary

The purpose of this study is to evaluate which treatment option for pelvic floor pain allows for improved sexual function.

Conditions

  • Dyspareunia

Interventions

DRUG

Trigger Point Injections Triamcinolone Acetonide, Bupivacaine Hydrochloride

The mixture is injected into the levator muscles, with half the volume on each side of the pelvic musculature.

PROCEDURE

Pelvic Rehabilitation

Pelvic floor massage will be performed on a weekly basis by a licensed physiotherapist specialized in pelvic floor pelvic therapy

Sponsors & Collaborators

  • Patty Brisben Foundation For Women's Sexual Health

    collaborator OTHER

  • University of Cincinnati

    lead OTHER

Principal Investigators

  • Mary South, MD · University of Cincinnati

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-04-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02022722 on ClinicalTrials.gov